Folker Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Folker Meyer has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Wilke
Clarkson University
27 shared publications - Alfred Pühler
Center for Biotechnology (CeBiTec), Bielefeld University, Genome Research of Industrial Microorganisms, D-33615 Bielefeld, Germany
24 shared publications - Alexander Goesmann
Institute of Bioinformatics and Systems Biology, Justus Liebig University Giessen, Giessen, Germany
21 shared publications Daniela Bartels
Computation Institute University of Chicago Chicago IL 60637 USA
20 shared publications- Nikos C. Kyrpides
DOE Joint Genome Institute, Lawrence Berkeley National Laboratory , 1 Cyclotron road, Berkeley, CA 94720
16 shared publications - William L. Trimble
Physics Division, Argonne National Laboratory, Argonne, Illinois 60439, USA
16 shared publications
Latest Publications
- 1 April 2026
- Published by Springer Nature
- p. 243-253
Which Metadata Matters? Evaluating Predictive Features for Environmental Time Series
- 1 April 2026
- Published by Springer Nature
- p. 243-253
Which Metadata Matters? Evaluating Predictive Features for Environmental Time Series
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 6 (1) , vbag153
stackPredAMR—a stacked random forest approach improves AMR phenotype prediction for multiple species and antimicrobial agents
Motivation: Antimicrobial resistance is a growing global threat, creating a need for rapid and accurate antimicrobial susceptibility testing. Current phenotypic antimicrobial susceptibility testing methods rely on prior isolation and cultivation, making them time-consuming. Whole genome sequencing combined with machine learning offers a faster and cost-effective alternative, but existing approaches are often limited in species coverage, antimicrobial scope, or data availability. Results: We developed stackPredAMR, a machine learning framework for predicting resistance to 18 antimicrobial agents in three clinically important bacterial species: Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii. The model uses antimicrobial resistance gene presence as input and incorporates cross-resistance patterns through a stacked architecture with two random forest layers. Benchmarking on more than 2500 publicly available whole genome sequencing datasets with linked phenotypic resistance data showed strong performance, achieving a median accuracy of 0.94, ROC AUC of 0.97, and F1-score of 0.91, outperforming previously published methods. stackPredAMR is freely available and designed to support future extension to additional species and antimicrobial agents. Availability and implementation: Source code and datasets (database-driven reference approach, sample lists, and input features) are available at WIN-KID repository (https://github.com/IKIM-Essen/WIN-KID/tree/v1.0.0.0) and the release page (https://github.com/IKIM-Essen/WIN-KID/releases/tag/v1.0.0.0).
- 7 January 2026
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 6 (1) , vbag153
Open AccessstackPredAMR—a stacked random forest approach improves AMR phenotype prediction for multiple species and antimicrobial agents
Motivation: Antimicrobial resistance is a growing global threat, creating a need for rapid and accurate antimicrobial susceptibility testing. Current phenotypic antimicrobial susceptibility testing methods rely on prior isolation and cultivation, making them time-consuming. Whole genome sequencing combined with machine learning offers a faster and cost-effective alternative, but existing approaches are often limited in species coverage, antimicrobial scope, or data availability. Results: We developed stackPredAMR, a machine learning framework for predicting resistance to 18 antimicrobial agents in three clinically important bacterial species: Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii. The model uses antimicrobial resistance gene presence as input and incorporates cross-resistance patterns through a stacked architecture with two random forest layers. Benchmarking on more than 2500 publicly available whole genome sequencing datasets with linked phenotypic resistance data showed strong performance, achieving a median accuracy of 0.94, ROC AUC of 0.97, and F1-score of 0.91, outperforming previously published methods. stackPredAMR is freely available and designed to support future extension to additional species and antimicrobial agents. Availability and implementation: Source code and datasets (database-driven reference approach, sample lists, and input features) are available at WIN-KID repository (https://github.com/IKIM-Essen/WIN-KID/tree/v1.0.0.0) and the release page (https://github.com/IKIM-Essen/WIN-KID/releases/tag/v1.0.0.0).
- 5 November 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (1) , 335
Author Correction: A roadmap for equitable reuse of public microbiome data
- 5 November 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 11 (1) , 335
Author Correction: A roadmap for equitable reuse of public microbiome data
- Open Access
- 26 September 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (10) , 2384-2395
A roadmap for equitable reuse of public microbiome data
Science benefits from rapid open data sharing, but current guidelines for data reuse were established two decades ago, when databases were several million times smaller than they are today. These guidelines are largely unfamiliar to the scientific community, and, owing to the rapid increase in biological data generated in the past decade, they are also outdated. As a result, there is a lack of community standards suited to the current landscape and inconsistent implementation of data sharing policies across institutions. Here we discuss current sequence data sharing policies and their benefits and drawbacks, and present a roadmap to establish guidelines for equitable sequence data reuse, developed in consultation with a data consortium of 167 microbiome scientists. We propose the use of a Data Reuse Information (DRI) tag for public sequence data, which will be associated with at least one Open Researcher and Contributor ID (ORCID) account. The machine-readable DRI tag indicates that the data creators prefer to be contacted before data reuse, and simultaneously provides data consumers with a mechanism to get in touch with the data creators. The DRI aims to facilitate and foster collaborations, and serve as a guideline that can be expanded to other data types.
- 26 September 2025
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (10) , 2384-2395
Open AccessA roadmap for equitable reuse of public microbiome data
Science benefits from rapid open data sharing, but current guidelines for data reuse were established two decades ago, when databases were several million times smaller than they are today. These guidelines are largely unfamiliar to the scientific community, and, owing to the rapid increase in biological data generated in the past decade, they are also outdated. As a result, there is a lack of community standards suited to the current landscape and inconsistent implementation of data sharing policies across institutions. Here we discuss current sequence data sharing policies and their benefits and drawbacks, and present a roadmap to establish guidelines for equitable sequence data reuse, developed in consultation with a data consortium of 167 microbiome scientists. We propose the use of a Data Reuse Information (DRI) tag for public sequence data, which will be associated with at least one Open Researcher and Contributor ID (ORCID) account. The machine-readable DRI tag indicates that the data creators prefer to be contacted before data reuse, and simultaneously provides data consumers with a mechanism to get in touch with the data creators. The DRI aims to facilitate and foster collaborations, and serve as a guideline that can be expanded to other data types.
- Open Access
- 31 August 2024
- Published by GigaScience Press in Gigabyte
- Vol. 2024
RiboSnake – a user-friendly, robust, reproducible, multipurpose and documentation-extensive pipeline for 16S rRNA gene microbiome analysis
Background Next-generation sequencing for microbial communities has become a standard technique. However, the computational analysis remains resource-intensive. With declining costs and growing adoption of sequencing-based methods in many fields, validated, fully automated, reproducible and flexible pipelines are increasingly essential in various scientific fields. Results We present RiboSnake, a validated, automated, reproducible QIIME2-based pipeline implemented in Snakemake for analysing 16S rRNA gene amplicon sequencing data. RiboSnake includes pre-packaged validated parameter sets optimized for different sample types, from environmental samples to patient data. The configuration packages can be easily adapted and shared, requiring minimal user input. Conclusion RiboSnake is a new alternative for researchers employing 16S rRNA gene amplicon sequencing and looking for a customizable and user-friendly pipeline for microbiome analyses with in vitro validated settings. By automating the analysis with validated parameters for diverse sample types, RiboSnake enhances existing methods significantly. The workflow repository can be found on GitHub (https://github.com/IKIM-Essen/RiboSnake).
- 31 August 2024
- Published by GigaScience Press in Gigabyte
- Vol. 2024
Open AccessRiboSnake – a user-friendly, robust, reproducible, multipurpose and documentation-extensive pipeline for 16S rRNA gene microbiome analysis
Background Next-generation sequencing for microbial communities has become a standard technique. However, the computational analysis remains resource-intensive. With declining costs and growing adoption of sequencing-based methods in many fields, validated, fully automated, reproducible and flexible pipelines are increasingly essential in various scientific fields. Results We present RiboSnake, a validated, automated, reproducible QIIME2-based pipeline implemented in Snakemake for analysing 16S rRNA gene amplicon sequencing data. RiboSnake includes pre-packaged validated parameter sets optimized for different sample types, from environmental samples to patient data. The configuration packages can be easily adapted and shared, requiring minimal user input. Conclusion RiboSnake is a new alternative for researchers employing 16S rRNA gene amplicon sequencing and looking for a customizable and user-friendly pipeline for microbiome analyses with in vitro validated settings. By automating the analysis with validated parameters for diverse sample types, RiboSnake enhances existing methods significantly. The workflow repository can be found on GitHub (https://github.com/IKIM-Essen/RiboSnake).
- Open Access
RiboSnake – a user-friendly, robust, reproducible, multipurpose and documentation-extensive pipeline for 16S rRNA gene microbiome analysis
Background: Next-generation sequencing for assaying microbial communities has become a standard technique in recent years. However, the initial investment required into in-silico analytics is still quite significant, especially for facilities not focused on bioinformatics. With the rapid decline in costs and growing adoption of sequencing-based methods in a number of fields, validated, fully automated, reproducible and yet flexible pipelines will play a greater role in various scientific fields in the future. Results: We present RiboSnake, a validated, automated, reproducible QIIME2-based analysis pipeline implemented in Snakemake for the computational analysis of 16S rRNA gene amplicon sequencing data. The pipeline comes with pre-packaged validated parameter sets, optimized for different sample types. The sets range from complex environmental samples to patient data. The configuration packages can be easily adapted and shared, requiring minimal user input. Conclusion: RiboSnake is a new alternative for researchers employing 16S rRNA gene amplicon sequencing and looking for a customizable and yet user-friendly pipeline for microbiome analysis with in-vitro validated settings. The complete analysis generated with a fully automated pipeline based on validated parameter sets for different sample types is a significant improvement to existing methods. The workflow repository can be found on GitHub ( https://github.com/IKIM-Essen/RiboSnake ).
Open AccessRiboSnake – a user-friendly, robust, reproducible, multipurpose and documentation-extensive pipeline for 16S rRNA gene microbiome analysis
Background: Next-generation sequencing for assaying microbial communities has become a standard technique in recent years. However, the initial investment required into in-silico analytics is still quite significant, especially for facilities not focused on bioinformatics. With the rapid decline in costs and growing adoption of sequencing-based methods in a number of fields, validated, fully automated, reproducible and yet flexible pipelines will play a greater role in various scientific fields in the future. Results: We present RiboSnake, a validated, automated, reproducible QIIME2-based analysis pipeline implemented in Snakemake for the computational analysis of 16S rRNA gene amplicon sequencing data. The pipeline comes with pre-packaged validated parameter sets, optimized for different sample types. The sets range from complex environmental samples to patient data. The configuration packages can be easily adapted and shared, requiring minimal user input. Conclusion: RiboSnake is a new alternative for researchers employing 16S rRNA gene amplicon sequencing and looking for a customizable and yet user-friendly pipeline for microbiome analysis with in-vitro validated settings. The complete analysis generated with a fully automated pipeline based on validated parameter sets for different sample types is a significant improvement to existing methods. The workflow repository can be found on GitHub ( https://github.com/IKIM-Essen/RiboSnake ).
- Open Access
A roadmap for fair reuse of public microbiome data
Science benefits from rapid, open data sharing but samples for sequencing data are expensive for data creators to acquire and process. Current guidelines for data reuse were established two decades ago, when databases were several million times smaller, necessitating an update. This article presents a roadmap to establish best practices for sequence data reuse, developed in consultation with a data consortium of 167 microbiome scientists. It introduces a Data Reuse Information tag (DRI) for public sequencing data, which will be associated with at least one Open Researcher and Contributor ID (ORCID) account. The machine-readable DRI tag indicates that the data creators prefer to be contacted prior to data reuse, and simultaneously provides data consumers with a mechanism to get in touch with the data creators. Ideally, the DRI will facilitate and foster collaborations, and serve as a guideline that can be expanded to other data types.
Open AccessA roadmap for fair reuse of public microbiome data
Science benefits from rapid, open data sharing but samples for sequencing data are expensive for data creators to acquire and process. Current guidelines for data reuse were established two decades ago, when databases were several million times smaller, necessitating an update. This article presents a roadmap to establish best practices for sequence data reuse, developed in consultation with a data consortium of 167 microbiome scientists. It introduces a Data Reuse Information tag (DRI) for public sequencing data, which will be associated with at least one Open Researcher and Contributor ID (ORCID) account. The machine-readable DRI tag indicates that the data creators prefer to be contacted prior to data reuse, and simultaneously provides data consumers with a mechanism to get in touch with the data creators. Ideally, the DRI will facilitate and foster collaborations, and serve as a guideline that can be expanded to other data types.
- Top Cited PapersOpen Access
- 19 June 2020
- Published by Springer Nature in Scientific Data
- Vol. 7 (1) , 188
COVID-19 pandemic reveals the peril of ignoring metadata standards
- 19 June 2020
- Published by Springer Nature in Scientific Data
- Vol. 7 (1) , 188
Top Cited PapersOpen AccessCOVID-19 pandemic reveals the peril of ignoring metadata standards
- Open Access
- 8 November 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (1) , 1-8
The MG-RAST API explorer: an on-ramp for RESTful query composition
Background: The MG-RAST API provides search capabilities and delivers organism and function data as well as raw or annotated sequence data via the web interface and its RESTful API. For casual users, however, RESTful APIs are hard to learn and work with. Results: We created the graphical MG-RAST API explorer to help researchers more easily build and export API queries; understand the data abstractions and indices available in MG-RAST; and use the results presented in-browser for exploration, development, and debugging. Conclusions: The API explorer lowers the barrier to entry for occasional or first-time MG-RAST API users.
- 8 November 2019
- Published by Springer Nature in BMC Bioinformatics
- Vol. 20 (1) , 1-8
Open AccessThe MG-RAST API explorer: an on-ramp for RESTful query composition
Background: The MG-RAST API provides search capabilities and delivers organism and function data as well as raw or annotated sequence data via the web interface and its RESTful API. For casual users, however, RESTful APIs are hard to learn and work with. Results: We created the graphical MG-RAST API explorer to help researchers more easily build and export API queries; understand the data abstractions and indices available in MG-RAST; and use the results presented in-browser for exploration, development, and debugging. Conclusions: The API explorer lowers the barrier to entry for occasional or first-time MG-RAST API users.